Casandra
Casandra Test Code AR51544Version 1 (DRAFT)
Performing Lab
Autoimmune Movement Disorder Panel, CSF (Change effective as of 4/21/25: Refer to 3018966 in the April Hotline)
Also known as: AIMDC
Clinical Use
Order TestUse
This panel is used to evaluate subacute‑onset movement disorders by detecting a range of neuronal autoantibodies in cerebrospinal fluid that are associated with autoimmune movement disorders. Identification of these antibodies can support diagnosis, guide clinical management, and inform evaluation for underlying causes including paraneoplastic syndromes.
Special Instructions
Not provided.
Limitations
Not stated explicitly in the provided content.
Test Details
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
16 targets
AMPA Receptor AbAmphiphysin AntibodyCASPR2 AbCV2 AbDPPX AbGABA‑AR AbGABA‑BR AbGlutamic Acid Decarboxylase Antibody+8 more
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Not provided.
Similar Tests
Other tests from different labs that may be relevant
Movement Disorder, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
Mayo Clinic Lab
Autoimmune Neurology/Comprehensive Paraneoplastic Profile, Spinal Fluid
Labcorp
Movement Disorder, Autoimmune/Paraneoplastic Evaluation, Serum
Mayo Clinic Lab
Dementia, Autoimmune/Paraneoplastic Evaluation, Serum
Mayo Clinic Lab
Dementia, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
Mayo Clinic Lab
Encephalopathy, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
Mayo Clinic Lab
Paraneoplastic Antibody Expanded Evaluation with Reflex to Titer and LB, CSF
Quest Diagnostics
Paraneoplastic Antibody Expanded Evaluation with Reflex to Titer and LB, Serum
Quest Diagnostics
Myelopathy, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
Mayo Clinic Lab
Myelopathy, Autoimmune/Paraneoplastic Evaluation, Serum
Mayo Clinic Lab